fluorine has been researched along with mocetinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, ZZ; He, Y; Pei, JJ; Shan, KR; Tu, X; Zhang, T | 1 |
| Aldib, I; Colet, JM; Conotte, R; Dufrasne, F; Elfving, B; Furtmüller, PG; Gelbcke, M; Kauffmann, JM; Nève, J; Obinger, C; Podrecca, M; Prévost, M; Reye, F; Rousseau, A; Sarakbi, A; Soubhye, J; Van Antwerpen, P; Vanhaeverbeek, M; Zouaoui Boudjeltia, K | 1 |
2 other study(ies) available for fluorine and mocetinostat
| Article | Year |
|---|---|
Myeloperoxidase activity and its corresponding mRNA expression as well as gene polymorphism in the population living in the coal-burning endemic fluorosis area in Guizhou of China.
Topics: Air Pollutants; China; Coal; Endemic Diseases; Fluorine; Fluorosis, Dental; Food Contamination; Gene Frequency; Haplotypes; Humans; Peroxidase; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2013 |
Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors.
Topics: Animals; Carboxylic Acids; Crystallization; Drug Design; Enzyme Inhibitors; Fluorine; Humans; Indicators and Reagents; Indoles; Lipoproteins, LDL; Male; Models, Molecular; Nitrogen; Oxidation-Reduction; Peroxidase; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Sulfur; Taurine | 2013 |